Deal value of biotech acquistions by Big Pharma is up almost 90% for 2008.
Biggest proposed deal thus far is Switzerland's Roche's $44m bid for Genentech, the San Francisco oncology-focused lab, of which it already owns a controlling share.
Drugs are a multi-billion dollar business. World's best-selling drug Lipitor, from Pfizer, generated $8.1 billion in sales in 2007. Lipitor is cholesterol-lowering medication.
Earlier this year, Daiichi Sankyo took over Malvinder Singh's Ranbaxy in a cash-deal worth $4.6bn. Ranbaxy is known for challenging the patents of pharmaceutical companies and pioneering the generic drugs industry.
No comments:
Post a Comment